Literature DB >> 14751822

Short interfering RNA (siRNA)-mediated RNA interference (RNAi) in human cells.

Natasha J Caplen1, Spyro Mousses.   

Abstract

Transient gene silencing in mammalian cells can be mediated by double stranded RNA (dsRNAs) molecules of approximately 20-25 nucleotides termed short interfering (siRNAs). Naturally occurring siRNAs in lower eukaryotes have characteristic structural elements; however, little is known about what features are critical for an exogenous siRNA to mediate RNAi in mammals. We have recently determined some of the critical parameters that influence the efficiency of siRNA-mediated RNAi in mammalian cells and have been considering the use of RNAi as a functional genomics tool, particularly for high throughput analysis, and the potential use of RNAi as a therapeutic tool.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14751822     DOI: 10.1196/annals.1281.007

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  16 in total

Review 1.  [Viral and nonviral gene therapy for treatment of retinal diseases].

Authors:  J Neidhardt; K Wycisk; B Klöckener-Gruissem
Journal:  Ophthalmologe       Date:  2005-08       Impact factor: 1.059

Review 2.  RNAi in embryonic stem cells.

Authors:  Li Ding; Frank Buchholz
Journal:  Stem Cell Rev       Date:  2006       Impact factor: 5.739

Review 3.  Epigenetics in sports.

Authors:  Tobias Ehlert; Perikles Simon; Dirk A Moser
Journal:  Sports Med       Date:  2013-02       Impact factor: 11.136

4.  Evaluation of glucocorticoid sensitivity in 697 pre-B acute lymphoblastic leukemia cells after overexpression or silencing of MAP kinase phosphatase-1.

Authors:  Marc T Abrams; Noreen M Robertson; Gerald Litwack; Eric Wickstrom
Journal:  J Cancer Res Clin Oncol       Date:  2005-03-15       Impact factor: 4.553

5.  Connexin-specific cell-to-cell transfer of short interfering RNA by gap junctions.

Authors:  V Valiunas; Y Y Polosina; H Miller; I A Potapova; L Valiuniene; S Doronin; R T Mathias; R B Robinson; M R Rosen; I S Cohen; P R Brink
Journal:  J Physiol       Date:  2005-07-21       Impact factor: 5.182

6.  Internally cationic polyamidoamine PAMAM-OH dendrimers for siRNA delivery: effect of the degree of quaternization and cancer targeting.

Authors:  Mahesh L Patil; Min Zhang; Oleh Taratula; Olga B Garbuzenko; Huixin He; Tamara Minko
Journal:  Biomacromolecules       Date:  2009-02-09       Impact factor: 6.988

7.  Regulation of hTERT transcription: a target of cellular and viral mechanisms for immortalization and carcinogenesis.

Authors:  Izumi Horikawa; Eriko Michishita; J Carl Barrett
Journal:  Cytotechnology       Date:  2004-06       Impact factor: 2.058

8.  Multifunctional triblock Nanocarrier (PAMAM-PEG-PLL) for the efficient intracellular siRNA delivery and gene silencing.

Authors:  Mahesh L Patil; Min Zhang; Tamara Minko
Journal:  ACS Nano       Date:  2011-02-15       Impact factor: 15.881

9.  Insights into the kinetics of siRNA-mediated gene silencing from live-cell and live-animal bioluminescent imaging.

Authors:  Derek W Bartlett; Mark E Davis
Journal:  Nucleic Acids Res       Date:  2006-01-12       Impact factor: 16.971

Review 10.  RNA-targeting and gene editing therapies for transthyretin amyloidosis.

Authors:  Alberto Aimo; Vincenzo Castiglione; Claudio Rapezzi; Maria Franzini; Giorgia Panichella; Giuseppe Vergaro; Julian Gillmore; Marianna Fontana; Claudio Passino; Michele Emdin
Journal:  Nat Rev Cardiol       Date:  2022-03-23       Impact factor: 49.421

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.